Probiotic Lactobacillus Acidophilus and L. Casei Mix Sensitize Colorectal Tumoral Cells to 5-Fluorouracil-Induced Apoptosis
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
To assess the potential of Lactobacillus acidophilus and Lactobacillus casei strains to increase the apoptosis of a colorectal cancer cell line in the presence of 5-fluorouracil (5-FU), LS513 colorectal cancer cells were treated for 48 h with increasing concentrations of these lactic acid bacteria (LAB) in the presence of 100 mu g/ml of 5-FU. In the presence of 10(8) CFU/ml of live LAB, the apoptotic efficacy of the 5-FU increased by 40%, and the phenomenon was dose dependent. Moreover, irradiation-inactivated LAB caused the same level of induction, whereas microwave-inactivated LAB reduced the apoptotic capacity of the 5-FU. When cells were treated with a combination of live LAB and 5-FU, a faster activation of caspase-3 protein was observed, and the p21 protein seems to be downregulated. These results suggest that live L. acidophilus and L. casei are able to increase the apoptosis-induction capacity of 5-FU. The mechanisms of action are still not elucidated, and more research is needed to understand them. This is the first set of experiments demonstrating that some strains of LAB can enhance the apoptosis-induction capacity of the 5-FU. Based on these results, it is possible to speculate that LAB or probiotics could be used as an adjuvant treatment during anticancer chemotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been also reported in several studies that Lactobacilli may stimulate host’s immune cells such as NK cells or dendritic cells (DC) or TH1 response, which, in turn, leads to the elimination of cancerous or precancerous cells, although the exact bacterial bioproduct mediating such stimulatory effect still needs to be identified [45,46,47,48].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [47]
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Analysis of apoptosis by propidium iodide staining and flow cytometry
Riccardi, C., & Nicoletti, I. (2006) · Nature Protocols · doi:10.1038/nprot.2006.238 · Cited by 1,685 · cited 1×
“The apoptosis evaluation was done by flow cytometry in presence of propidium iodide (according to (18)).”
MethodHaupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136 · cited 2×
“Moreover, Borralho et al. (33) demonstrated that 5-FU exerts its cytotoxic effects, in part, through a p53/Fas-dependent apoptotic pathway that involves Bax translocation and mitochondrial permeabilization.”
BackgroundGaldeano, C. M., & Perdigón, G. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.2.219-226.2006 · Cited by 535 · cited 1×
“First, in this type of experiment, it was not possible to verify if immune system modulation could interfere in this proapoptotic effect, although it is known that the modulation of the immune system is a strain-specific property that is widely recognized for many probiotic LAB (22,23).”
BackgroundAdolfsson, O., Meydani, S. N., & Russell, R. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.245 · Cited by 531 · cited 1×
“The preservative role and health benefits of fermented milk (7), kefir (8), and yogurt (9) are now recognized.”
BackgroundSystemic Treatment of Colorectal Cancer
Wolpin, B. M., & Mayer, R. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.098 · Cited by 504 · cited 13×
“Food and Drug Administration (FDA) for the treatment of CRC (5).”
BackgroundInfluentialCancer burden in the aged: An epidemiologic and demographic overview
Yancik, R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971001)80:7<1273::aid-cncr13>3.0.co;2-4 · Cited by 473
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria
Foligne, B. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i2.236 · Cited by 432 · cited 1×
“First, in this type of experiment, it was not possible to verify if immune system modulation could interfere in this proapoptotic effect, although it is known that the modulation of the immune system is a strain-specific property that is widely recognized for many probiotic LAB (22,23).”
BackgroundÖsterlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., Kouri, M., Elomaa, I., & Joensuu, H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603990 · Cited by 405 · cited 1×
“(40) demonstrated that the consumption of gelatine capsules twice daily, containing about 1 to 2 × 1010 of L.”
BackgroundSensitization of Cancer Cells Treated With Cytotoxic Drugs to Fas-Mediated Cytotoxicity
Micheau, O., Solary, E., Hammann, A., Martin, F., & Dimanche-Boitrel, M.-T. (1997) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.783 · Cited by 281 · cited 8×
“The treatment of LS513 cells with 5-FU increased the expression of p21; but unlike what was observed with p53 and Fas, the combination of 5-FU and live or microwave-inactivated LAB resulted in changes of p21 protein expression.”
BackgroundInfluential
Research works printed but not linked: 6
- Canadian Cancer Statistics, 2008
- 10.1002/(SICI)1097-0142(19971001)80:7<1179::AID-CNCR1>3.0.CO;2-G · doi:10.1002/(sici)1097-0142(19971001)80:7<1179::aid-cncr1>3.0.co;2-g
- 2006, Probiotics in food health and nutritional properties and guidelines for evaluation
- Macdonald J S, 2004, Cancer Chemother Pharmacol, 54, S4
- Ciccolini J, 2000, Clin Cancer Res, 6, 1529
- Javelaud J, 2000, Med Sci, 16, 265
Cited by
Items 101–170 of 170
Sharma, A., Arora, M., Goyal, A. K., & Rath, G. (2017) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-017-9258-x · Cited by 11
The role of microbiota in colorectal cancer
Khosravi, A. D., Seyed–Mohammadi, S., Teimoori, A., & Dezfuli, A. A. Z. (2022) · Folia Microbiologica · doi:10.1007/s12223-022-00978-1 · Cited by 10
“could be used as an adjuvant treatment during anticancer chemotherapy (Baldwin et al. 2010).”
BackgroundProbiotics and Colorectal Cancer
Raman, M., Ambalam, P. S., & Doble, M. (2015) · Springer eBooks · doi:10.1007/978-81-322-2586-7_2 · Cited by 12
Potential of Synbiotics and Probiotics as Chemopreventive Agent
Chin, K. W., Khoo, S. C., Paul, R. P. M., Luang‐In, V., Lam, S. D., & Ling, N. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10299-z · Cited by 12
The role of nutrition in harnessing the immune system: a potential approach to prevent cancer
Xiaogang, H., Sharma, M., Saif, I., Ali, G., Li, X., & Salama, E. (2022) · Medical Oncology · doi:10.1007/s12032-022-01850-5 · Cited by 13
Prospect of bacteria for tumor diagnosis and treatment
Xu, Y., Zhao, C., Ma, X., & Zhang, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121215 · Cited by 9
Overview of the Mechanistic Potential of Probiotics and Prebiotics in Cancer Chemoprevention
Bahuguna, A., & Dubey, S. K. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300221 · Cited by 12
The efficacy and toxicity of antineoplastic antimetabolites: Role of gut microbiota
Huang, X., Chen, L., Li, Z., Zheng, B., Liu, N., Fang, Q. Z., Jiang, J., Rao, T., & Ouyang, D. (2021) · Toxicology · doi:10.1016/j.tox.2021.152858 · Cited by 13
Jang, J. Y., Seo, J. H., Choi, J., Ryu, H. J., Yun, H., Ha, D. M., & Yang, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5560 · Cited by 9
Mavromatis, P., Stampouli, K., Vliora, A., Mayilyan, A., Samanidou, V., & Touraki, M. (2022) · Separations · doi:10.3390/separations9110376 · Cited by 9
Lactobacillus for ribosome peptide editing cancer
Yue, S., He, Q., & Picimbon, J. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-022-03066-5 · Cited by 9
Anti-cancer Activity of Human Gastrointestinal BacteriaPreprint
Quazi, S. (2021) · Preprints.org · doi:10.20944/preprints202112.0433.v1 · Cited by 6
Probiotics: Origin, Products, and Regulations in India
Narula, A. (2021) · Microorganisms for Sustainability · doi:10.1007/978-981-16-1947-2_4 · Cited by 6
RETRACTED ARTICLE: Anti-cancer activity of human gastrointestinal bacteria
Quazi, S. (2022) · Medical Oncology · doi:10.1007/s12032-022-01771-3 · Cited by 12
“Lactobacilli have also been shown to stimulate host immune cells such as NK cells, dendritic cells (DC), or the TH1 response, leading to the elimination of cancerous or precancerous cells [75–78].”
RetractedMucin Binding Protein of Lactobacillus casei Inhibits HT-29 Colorectal Cancer Cell Proliferation
Ju, X., Wu, X., Chen, Y., Cui, S., Cai, Z., Zhao, L., Hao, Y., Zhou, F. L., Chen, F., Yu, Z., et al. (2023) · Nutrients · doi:10.3390/nu15102314 · Cited by 7
“casei reduced its apoptosis capacity [29].”
Probiotics as a Therapeutic Approach in Colorectal Cancer
Rahmani, N., Pourali, G., Hosseini, N., Fiuji, H., Maftooh, M., Hassanian, S. M., Ferns, G. A., Khazaei, M., & Avan, A. (2023) · Current Cancer Drug Targets · doi:10.2174/1568009623666230413081513 · Cited by 6
Lactobacillus in cancer therapy: A critical mechanistic review
Baker, D. H. A. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.102256 · Cited by 9
Exploring marine Lactobacillus and its protein for probiotic-based oral cancer therapy
Vidya, S. L., Thiruneelakandan, G., Krishnamoorthy, R., Subbarayan, S., Maran, B. A. V., Alshuniaber, M. A., Gatasheh, M. K., Sunday, B. Y., & Ahmad, A. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127652 · Cited by 8
Mahooti, M., Safaei, F., Firuzpour, F., Abdolalipour, E., Zare, D., Sanami, S., Safavi, M., & Mirdamadi, S. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01855-2 · Cited by 8
Xiong, Y., Song, W., Shen, L., Wang, Y., Zhang, J., Hu, M., Liu, Y., Li, J., Musetti, S., Liu, R., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000168 · Cited by 5
Abdorrashidi, M., Heiat, M., Yeganeh, A. V., Tohidinia, A., Alizadeh, A., Ramazani, A., Gholizadeh, H., Pouraskar, T., & Peypar, M. H. (2025) · BioMed Research International · doi:10.1155/bmri/4216722 · Cited by 4
“This combination led to a more rapid activation of Cleaved Caspase-3 protein [38].”
The Impact of the Intestinal Microbiota in Therapeutic Responses Against Cancer
Bonvalet, M., Daillère, R., Roberti, M. P., Rauber, C., & Zitvogel, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_27 · Cited by 5
Megeed, R. M. A., Ismail, S. A., & Kadry, M. O. (2025) · OpenNano · doi:10.1016/j.onano.2025.100239 · Cited by 5
ZibasazTalebi, A., & Ahmadizadh, C. (2020) · journal of ilam university of medical sciences · doi:10.29252/sjimu.28.4.25 · Cited by 5
Nair, A., Tungare, K., De, A., & Jobby, R. (2024) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2023049792 · Cited by 4
Microbial Production of Bioactive Pigments, Oligosaccharides, and Peptides
Hernández‐Almanza, A., Márquez, D. B. M., de la Rosa, O., Navarro, V., Martínez-Medina, G. A., Rodríguez-Herrera, R., & Aguilar, C. N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811372-1.00004-x · Cited by 6
“Several studies demonstrate that some strains of bifidobacteria and lactobacilli are considered very important probiotics for human health (Baldwin et al., 2010; Liu et al., 2016; Orlando et al., 2012; Zhang et al., 2012).”
BackgroundSoopramanien, M., Khan, N. A., & Siddiqui, R. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.14981 · Cited by 4
“…Lactobacilli have also demonstrated anticancer activity by, in turn, stimulating the host immune system by triggering natural killer (NK) cells or dendritic cells (DC) or TH1 response, to target and fight against the early stages of cancer (Lee et al. 2004; Baldwin et al. 2010; Lenoir et al. 2016).”
BackgroundOral supplementation with lactobacilli to prevent colorectal cancer in preclinical models
Settanni, C. R., Quaranta, G., Bibbò, S., Gasbarrini, A., Cammarota, G., & Ianiro, G. (2020) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.19.02631-x · Cited by 5
Soleymani, S., Ebrahimi, F., Rezaeizadeh, H., & Rahimi, R. (2021) · Food bioactive ingredients · doi:10.1007/978-3-030-74035-1_18 · Cited by 6
Review on Dietary Factors in Fermented Foods and their Efficacy in Disease Management
Paari, K. A., Kurian, C., & Mathur, A. (2022) · Current Nutrition & Food Science · doi:10.2174/1573401318666220118144750 · Cited by 3
Microbiome Diagnostics and Interventions in Health and Disease
Dasgupta, N., Srivastava, A., Rao, A., Murugkar, V., Shroff, R., & Das, G. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_10 · Cited by 5
Produtos lácteos probióticos e câncer – uma revisão narrativa
Rosa, L. D. S., da Cruz, A. G., & Teodoro, A. J. (2022) · Research Society and Development · doi:10.33448/rsd-v11i5.28221 · Cited by 8
Dadashi, M., Sahebi, A., Arjmand-Teymouri, R., Mirzaii, M., Mousavian, M., & Yaslianifard, S. (2022) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid-116165 · Cited by 4
Importance of Gut Microbiome-Based Therapeutics in Cancer Treatment
Bazaz, M. R., Rahman, Z., Qadir, I., Pasam, T., & Dandekar, M. P. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_24 · Cited by 3
Probiotics as Potential Therapeutics for Colorectal Cancer
Chung, M. J. (2020) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2020.09.001362 · Cited by 3
“reuteri significantly down-regulates expression of nuclear factorkappaB (NF-κB)-dependent gene products that in turn regulate expression of survival genes such as Bcl-2 and Bcl-xL [29].”
BackgroundSalek, S., Moazamian, E., Mohammadi‐Bardbori, A., & Shamsdin, S. A. (2024) · Folia Microbiologica · doi:10.1007/s12223-024-01228-2 · Cited by 2
“According to the experimental studies on animal models, probiotics have anticancer (Baldwin et al. 2010; Budu et al. 2022; Chang and Pan 2018; Salek et al. 2024), anti-diabetic, antioxidant (Nataraj et al. 2020), and antibacterial activities (Hemarajata and Versalovic 2013), inhibit…”
Harnessing engineered bacteria for revolutionizing cancer immunotherapy
Zhou, K., Cao, L., Luo, H.-Y., Wang, K.-N., Song, Z., & Bu, L. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-01664-3 · Cited by 2
Probiotics Cancer Interaction, Prevention, and Therapy
Saebi, M., Barjasteh, A. H., Mahmoudi, M., Kheder, R. K., Ramazanpour, S., Ebadpour, N., Fadaee, A., & Esmaeili, S. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70435 · Cited by 2
Probiotic Modulation of Intestinal Cell Apoptosis in Inflammatory Bowel Disease and Colon Cancer
MunoznAtienza, E. (2016) · Immunotherapy Open Access · doi:10.4172/2471-9552.1000101 · Cited by 2
“(2010) [12] demonstrated a synergistic pro-apoptotic effect of the combination of a chemotherapeutic agent, 5-fluorouracil, and a mixture of viable L.”
BackgroundTherapeutic Application of Microbial Metabolites in Free Radical–Induced Tumorigenesis
Chattopadhyay, I. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_7 · Cited by 2
Ardestani, S. K., Tafvizi, F., & Ebrahimi, M. T. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Effects of Lactobacillus casei Culture Supernatant on Differentiation of K562 Cell Line
Maftuni, K., & Zare, P. (2017) · Medical Laboratory Journal · doi:10.29252/mlj.11.5.16 · Cited by 2
Investigation of peanut resi-due in cakes sold in Istanbul
Çetin, A. S., Çolak, H., & Hampikyan, H. (2020) · Food and Health · doi:10.3153/fh20028 · Cited by 2
“In a study carried out by Baldwin et al. (2010), L. acidophilus and L. casei probiotics were found to be apoptosis inducers when tested on colorectal carcinoma cell line, suggesting that probiotic bacteria itself may possess an anticancer activity.”
BackgroundHadid, M. A., Al-Shaibani, A. B. A., & Al-Halbosiy, M. M. F. (2023) · Journal of AL-Farabi for Medical Sciences · doi:10.59746/jfms.v1i1.24 · Cited by 1
Microbiome‐urothelium crosstalk in bladder cancer: From dysbiosis to clinical translation
Xu, H., Li, Z., Yang, L., Zheng, J., Li, W., Liao, R., Huang, W., Sun, B., Li, Z., Ma, C., et al. (2026) · iMetaOmics. · doi:10.1002/imo2.70081 · Cited by 1
“Other strains, such as Lactobacillus acidophilus and Lactobacillus casei , may sensitize tumor cells to apoptosis induced by 5 ‐ fluorouracil [202], and the bacteriocin nisin can enhance the efficacy of doxorubicin [203].”
Saikia, T., Das, S., Rajak, P., & Kalita, J. M. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117032 · Cited by 1
Bacterial-based cancer therapy: mechanisms and therapeutic advances
Sharifi, A. H., Phong, N. H. T., Marek, A., Kamal, M. A., Al-Kodmany, S., Tran, D. B., & Yamada, T. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00524-2 · Cited by 1
“Obli-gate anaerobes such as Clostridium and Bifidobacterium preferentially thrive in these oxygen-deficient niches, where they can colonize and replicate [53, 58].”
Research progress on the relationship between intestinal microflora and colorectal cancer
Zhan, H., & Liang, H. (2015) · Clinical Oncology and Cancer Research · doi:10.3969/j.issn.1000-8179.20150252 · Cited by 2
Prabhakar, P. K., Mishra, Y., & Mishra, V. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_2 · Cited by 2
Synbiotics in Gastroesophageal Cancer
Jha, S. K., Pandey, S., Karn, A., & Panthi, V. K. (2023) · Springer eBooks · doi:10.1007/978-981-19-7550-9_15 · Cited by 1
Rajesh, G., Ragunathan, R., & Johney, J. (2025) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3395 · Cited by 2
RETRACTED CHAPTER: Changing Paradigm of Probiotics from Functional Foods to Biotherapeutic Agents
Johnson, E. M., Jung, Y., Jin, Y., Yang, S. H., Jayabalan, R., & Suh, J. W. (2018) · Springer eBooks · doi:10.1007/978-981-10-7140-9_3 · Cited by 1
RetractedAn overview of probiotics and their role in cancer management
Bonyadi, F., Tukmechi, A., & Hadi, M. (2014) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences · Cited by 1
Jam, S. A. M., Khosroushahi, A. Y., Alipour, M., & Alipour, B. (2020) · Journal of Research in Clinical Medicine · doi:10.34172/jrcm.2020.008 · Cited by 1
Mechanism of Probiotics in the Colon Cancer Treatment
Lihong, P. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.26.004379 · Cited by 1
“Propionibacterium freudenreichii promotes the production of reactive oxygen species by secreting SCFA, which leads to the loss of mitochondrial transmembrane potential, the activation of caspase 3, and induces apoptosis of human colon and gastric cancer cell lines [8].”
BackgroundTaheri, F., Moazamian, E., & Mahdavi, M. (2021) · Immunoregulation · doi:10.32598/immunoregulation.3.2.3 · Cited by 1
“Thus, probiotic bacteria may suppress and remove the tumor by boosting the immune system [9, 24].”
BackgroundSarand, M. B., & Ahmadizadeh, C. (2019) · Medical Journal of Tabriz University of Medical Sciences and Health Services · doi:10.34172/mj.2020.002
Therapeutic Application of Microbial Metabolites in Free Radical Induced Tumorigenesis
Chattopadhyay, I. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_7-1
Fareez, I. M., Lim, S. M., & Ramasamy, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1907188/v1
Bioencapsulation for probiotics
Zaidel, D. N. A., Hashim, Z., Muhamad, I. I., Iemsam-arng, J., Dailin, D. J., Manas, N. H. A., Yaakob, H., & Zainol, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91229-7.00003-9
Probiotics-based Anticancer Immunity In Colon Cancer
Techo, S., Kingkaew, E., & Tanasupawat, S. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124781123030007
Gut Microbiome and Colorectal Cancer
Gweon, T. (2023) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2023.089 · Cited by 2
A Review on Probiotics and Their Role in the Management of Cancer
Dahiya, R., Khan, S., & Kumar, S. (2024) · Current Probiotics · doi:10.2174/0126666499270987231218145156
Shamsaee, F., Mohammadpour, S., Bahrami, A., Bahrami, M. K., Kosari‐Nasab, M., Zarrini, G., & Mahdavi, M. (2025) · Iranian Journal of Science · doi:10.1007/s40995-025-01909-8
Additional file 1 of Microbial signatures and continuum in endometrial cancer and benign patients
Semertzidou, A., Whelan, E., Smith, A., Ng, S. Q. Y., Roberts, L. A., Brosens, J. J., Marchesi, J. R., Bennett, P. R., MacIntyre, D. A., & Kyrgiou, M. (2024) · Figshare · doi:10.6084/m9.figshare.26143658
Darafsheh, M., Osgoei, L. T., Eslamimahmoudabadi, M., Aghayan, S. K., & Ghaleh, H. E. G. (2026) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2026.129.1.4
Khiavi, A. N., Lahimchi, M. H., Fard, A. M., Heydari, M. R., & Aghayan, S. K. (2026) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2026.101294
Shao, T., Li, M., Li, S., Pu, J., Li, C., & Guo, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1945287
“With respect to Lactobacillus fermentum preparations, a mixture of L. acidophilus and L. casei increases the capacity of 5-FU to induce apoptosis, enhancing the apoptosis-inducing effect of 5-FU by 40% (162).”
Chen, Z.-X., Guo, Y.-X., Han, J., & Hu, M. (2026) · ACS Food Science & Technology · doi:10.1021/acsfoodscitech.6c00578
Metadata
- Authors
- Baldwin∗, C., Millette∗, M., Oth †, D., Ruiz, M. T., Luquet, F.-M., & Lacroix, M.
- Affiliations
- Bio-K+ International (Canada) (CA)
- Institut National de la Recherche Scientifique (CA)
- ORCID
- Lacroix, Monique
- Venue
- Nutrition and Cancer
- Publisher
- Informa UK Limited
- Published
- 2010-04-05
- Volume
- 62
- Issue
- 3
- Pages
- 371-378
- ISSN
- 0163-5581 (ISSN-L)
- 1532-7914
- OpenAlex
- W2057808496
- Cited by
- 170
- References
- 39
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 16 · 2023: 14 · 2022: 22 · 2021: 20 · 2020: 25 · 2019: 8 · 2018: 6 · 2017: 8 · 2016: 6 · 2015: 11 · 2014: 5 · 2013: 6 · 2012: 3
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nutrition and Cancer (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- EspaceINRS (National Institute for Scientific Research (Canada)) (submittedVersion)
- Funders
- U.S. Food and Drug Administration
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- Lactobacillus acidophilus, Lactobacillus casei, probiotics, lactic acid bacteria, 5-fluorouracil, apoptosis, colorectal cancer, caspase-3, p21, adjuvant chemotherapy, radiation inactivation
- MeSH terms
- Antimetabolites, Antineoplastic, Fluorouracil, Humans, Lactobacillus acidophilus, Lacticaseibacillus casei, Colorectal Neoplasms, Apoptosis, Probiotics, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor p21, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.